Conjugation of Ligands at the 5‘-End of CpG DNA Affects Immunostimulatory Activity

Tokunaga T., 1984, J. Natl. Cancer Inst., 72

Messina J. P., 1991, J. Immunol., 147, 10.4049/jimmunol.147.6.1759

Krieg A. M., 1995, CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546−549

Sato Y., 1996, Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352−354

Gurunathan S., 2000, Annu. Rev. Immunol., 18, 10.1146/annurev.immunol.18.1.927

Krieg A. M., 2002, Annu. Rev. Immunol., 20, 10.1146/annurev.immunol.20.100301.064842

Agrawal S., 2002, Medicinal chemistry and therapeutic potential of CpG DNA. Trends Mol. Med. 8, 114−121

Hemmi H., 2000, A Toll-like receptor recognizes bacterial DNA. Nature 408, 740−745

Chu W., 2000, DNA-PKcs is required for activation of innate immunity by immunostimulatory DNA. Cell 103, 909−918

Takeshita F., 2001, J. Immunol., 167, 10.4049/jimmunol.167.7.3555

Bauer S., 2001, Proc. Natl. Acad. Sci. U.S.A. 98

Tokunaga T., 1992, Microbiol. Immunol., 36, 66, 10.1111/j.1348-0421.1992.tb01642.x

Hartmann G., 2000, J. Immunol., 164

Verthelyi D., 2001, J. Immunol., 166, 10.4049/jimmunol.166.4.2372

Kandimalla E. R., 2001, Effect of chemical modifications of cytosine and guanine in a CpG-motif of oligonucleotides:  structure-immunostimulatory activity relationships. Bioorg. Med. Chem. 9, 807−813

Zhao Q., 1996, Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochem Pharmacol. 51, 173−182

Zhao Q., 1999, Bioorg. Med. Chem. Lett., 9

Zhao Q., 2000, Bioorg. Med. Chem. Lett., 10

Yu D., 2001, Immunostimulatory activity of CpG oligonucleotides containing nonionic methylphosphonate linkages. Bioorg. Med. Chem. 9, 2803−2808

Yu D., 2001, Bioorg. Med. Chem. Lett., 11

Yu D., 2002, Immunostimulatory properties of phosphorothioate CpG DNA containing both 3‘-5‘- and 2‘-5‘-internucleotide linkages. Nucleic Acids Res. 30, 1613−1619

Cho H. J., 2000, Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism. Nat. Biotechnol. 18, 509−514

Tighe H., 2000, J. Allergy Clin. Immunol., 106, 10.1067/mai.2000.107927

Tighe H., 2000, Eur. J. Immunol., 30, 10.1002/1521-4141(200007)30:7<1939::AID-IMMU1939>3.0.CO;2-#

Shirota H., 2000, J. Immunol., 164, 10.4049/jimmunol.164.11.5575

Shirota H., 2001, J. Immunol., 167, 74, 10.4049/jimmunol.167.1.66

Yu D., 2000, Bioorg. Med. Chem. Lett., 10

Kandimalla E. R., 1995, J. Am. Chem. Soc., 117, 10.1021/ja00128a055

Kandimalla, E. R., and Agrawal, S. (1996) Hoogsteen DNA duplexes of 3‘-3‘- and 5‘-5‘-linked oligonucleotides and triplex formation with RNA and DNA pyrimidine single strands:  Experimental and molecular modeling studies.Biochemistry35, 15332−15339.

Chaix C., 1996, Bioorg. Med. Chem. Lett., 6, 10.1016/0960-894X(96)00115-1

Iyer R. P., 1990, J. Am. Chem. Soc., 112

Branda R. F., 1993, Biochem. Pharmacol. 45

Schreiber E., 1989, Rapid detection of octamer binding proteins with 974 ‘mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17, 6419−6420

Bradford M. M., 1976, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248−254

Zhu F.-G., 2001, Role of the heat shock protein 90 in immune response stimulation by bacterial DNA and synthetic oligonucleotides. Infect. Immun. 69, 5546−5552

Lisziewicz J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91

Hacker G., 2002, Activation of the immune system by bacterial CpG-DNA. Immunology 105, 245−251

Temsamani J., 1997, vivo metabolic profile of a phosphorothioate oligodeoxyribonucleotide. Antisense Nucleic Acid Drug Dev. 7, 159−165

Temsamani J., 1995, Nucleic Acids Res. 23

Agrawal S., 1991, Proc. Natl. Acad. Sci. U.S.A. 88

Temsamani J., 1992, Capped oligodeoxynucleotide phosphorothioates. Pharmacokinetics and stability in mice. Ann. N. Y. Acad. Sci. 660, 318−320

Temsamani J., 1993, Pharmacokinetics, biodistribution, and stability of capped oligodeoxynucleotide phosphorothioates in mice. Antisense Res. Dev. 3, 277−284

Levis J. T., 1994, Properties of exonuclease-resistant, psoralen-conjugated oligodeoxyribonucleotides in vitro and in cell culture. Antisense Res Dev. 4, 231−241

Pandolfi D., 1999, Nucleosides Nucleotides 18

Agrawal S., 2000, Mol. Med. Today, 6, 81

Agrawal S., 1996, Effect of G-rich sequences on the synthesis, purification, binding, cell uptake, and hemolytic activity of oligonucleotides. Bioorg. Med. Chem. Let. 6, 2219−2224

Lee S. W., 2000, J. Immunol., 165

Agrawal S., 1986, Efficient methods for attaching nonradioactive labels to the 5‘ ends of synthetic oligodeoxyribonucleotides. Nucleic Acids Res. 14, 6227−6245